NR 566 Week 5 Immunization Assignment
Immunization Chamberlain University College of Nursing NR: Advanced Pharmacology for Care of the Family November 22, 2020 IMMUNIZATION Immunizations take part in a crucial role in preventing illness by providing protection. Getting acquainted with the most current guidelines and recommendations on two available vaccinations to avert the occurrence of vaccine-preventable illnesses in the United States is the main intent of this paper. The human papillomavirus (HPV) vaccine and the hepatitis B vaccine with their trade names, categories of vaccination, contraindications, precautions, adverse effects, and the minimum recommended age to receive the vaccine, correct timing, and dose, and relevant special circumstances are elucidated further in detail. Finally, barriers and interventions to incorporate the reasons for reluctance to obtain the vaccine, interventions for increased compliance, and the obligation to report adverse events linked with the vaccine are discussed. Human Papillomavirus Vaccine (HPV) The trade name of HPV based on the Centers for Disease Control and Prevention (2020b) is Gardasil 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] categorized as a subunit type of a recombinant, polysaccharide, and conjugate vaccine. Severe allergic reactions or anaphylaxis are contraindicated to the vaccine's yeast component (U.S. Department of Health & Human Services, 2020). The presence of acute illness that could be moderate or severe with or without fever is a precaution (Centers for Disease Control and Prevention, 2020a). Adverse effects and risks from the HPV vaccine are pain, redness, swelling at the injection spot, syncope, fever, or headache (Centers for Disease Control and Prevention, 2020). The minimum age requirement should be nine years old when the first dose of the HPV vaccine can be given and then nine years plus five months for the second dose to complete the recommended HPV two-dose series (Centers for Disease Control and Prevention, 2020c).
Información del documento
- Subido en
- 13 de diciembre de 2021
- Número de páginas
- 7
- Escrito en
- 2021/2022
- Tipo
- Examen
- Contiene
- Preguntas y respuestas